Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jcmm.15620 http://scihub22266oqcxt.onion/10.1111/jcmm.15620 32864865!7576249!32864865     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Cell+Mol+Med 2020 ; 24 (19): 11603-11606 Nephropedia Template TP {{tp|p=32864865|t=2020. The phenotypic changes of gammadelta T cells in COVID-19 patients |pdf=|usr=}}{{32864865}} gab.com Text The phenotypic changes of gammadelta T cells in COVID-19 patients JO: J Cell Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=32864865 #FOAvip A novel pneumonia-associated respiratory syndrome named coronavirus disease-2019 (COVID-19), which was caused by SARS-CoV-2?broke out in Wuhan, China, in the end of 2019. Unfortunately, there is no specific antiviral agent or vaccine available to treat SARS-CoV-2 infections. The information regarding the immunological characteristics in COVID-19 patients remains limited. Here, we collected the blood samples from 18 healthy donors (HD) and 38 COVID-19 patients to analyze changes on gammadelta T cell population. In comparison with HD, the gammadelta T cell percentage decreased, while the activation marker CD25 expression increased in response to SARS-CoV-2 infection. Interestingly, the CD4 expression was upregulated in gammadelta T cells reflecting the occurrence of a specific effector cell population, which may serve as a biomarker for the assessment of SARS-CoV-2 infection. Twit Text FOAVip The phenotypic changes of gammadelta T cells in COVID-19 patients ????J Cell Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=32864865 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32864865 #FOAvip English Wikipedia <ref>{{Cite pmid|32864865}}</ref> The phenotypic changes of gammadelta T cells in COVID-19 patients #MMPMID32864865 Lei L; Qian H; Yang X; Zhang X; Zhang D; Dai T; Guo R; Shi L; Cheng Y; Zhang B; Zhou X; Hu J; Guo Y J Cell Mol Med 2020[Oct]; 24 (19): 11603-11606 PMID32864865show ga A novel pneumonia-associated respiratory syndrome named coronavirus disease-2019 (COVID-19), which was caused by SARS-CoV-2?broke out in Wuhan, China, in the end of 2019. Unfortunately, there is no specific antiviral agent or vaccine available to treat SARS-CoV-2 infections. The information regarding the immunological characteristics in COVID-19 patients remains limited. Here, we collected the blood samples from 18 healthy donors (HD) and 38 COVID-19 patients to analyze changes on gammadelta T cell population. In comparison with HD, the gammadelta T cell percentage decreased, while the activation marker CD25 expression increased in response to SARS-CoV-2 infection. Interestingly, the CD4 expression was upregulated in gammadelta T cells reflecting the occurrence of a specific effector cell population, which may serve as a biomarker for the assessment of SARS-CoV-2 infection. |Adult[MESH] |Betacoronavirus/physiology[MESH] |Biomarkers[MESH] |CD4 Antigens/metabolism[MESH] |COVID-19[MESH] |China[MESH] |Coronavirus Infections/*immunology[MESH] |Flow Cytometry[MESH] |Humans[MESH] |Immunity, Innate[MESH] |Interleukin-2 Receptor alpha Subunit/metabolism[MESH] |Pandemics[MESH] |Pneumonia, Viral/*immunology[MESH] |SARS-CoV-2[MESH]The phenotypic changes of gammadelta T cells in COVID-19 patients (epmc).pdf DeepDyve Pubget Overpricing